Linda Marbán is Chief Executive Officer of Capricor Therapeutics, Inc. (CAPR). The company reported total compensation of $3,521,565 for fiscal year 2025.
| Salary | $300,000 |
|---|---|
| Bonus | $270,000 |
| Stock awards | $0 |
| Option awards | $2,940,920 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $10,645 |
| Total | $3,521,565 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Capricor Therapeutics, Inc. filed April 10, 2026, accession 0001104659-26-042070.
| Peer-group chief executive median | $6,323,334 |
|---|---|
| Difference from that median | $-2,801,768 |
| Percentile within the disclosed peer group | 50th |
| Peers with a disclosed figure | 2 |
Medians and percentiles are computed across the peer group Capricor Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Linda Marbán this page | Chief Executive Officer | $3,521,565 |
| Anthony Bergmann | Chief Financial Officer | $1,670,792 |
| Karen Krasney | Executive Vice President & General Counsel | $1,269,558 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Capricor Therapeutics, Inc. compensation brief.
Linda Marbán's compensation sits inside Capricor Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.